GREEN partners are inventors of many patents including the discovery of compounds of interest for Alzheimer’s disease and Multiple sclerosis, validation of biomarkers, devices for delivery of compounds, new methods for brain printing and the generation of innovative stimulation devices.
GREEN partners have been directly involved in the creation of Startups
PiXyl, found in 2015, delivers precise neuroimaging biomarker extraction for improved insight and decision-making in clinical studies and routine clinical practice. Pixyl automatic neuroimaging segmentation plugins are designed for seamless integration into the workflows of imaging CROs, neuroradiologists and neurologists. Manual segmentation methods are subjective, time-consuming and costly. They demonstrate an inherent variability that can be reduced by using objective and repeatable automatic methods. Pixyl powers the next-generation of medical image analysis platforms.
M Dojat, GIN member, is Pixyl co-Founder and scientific consultant.
SynapCell SAS, founded in 2005, is a drug discovery focused CRO specializing in CNS. SynapCell provides the pharmaceutical and biotech industries with translational drug discovery solutions to reveal the therapeutic potential of their molecules for CNS disorders. 2 exclusive licenses for epilepsy and schizophrenia rodent models.
> www.synapcell.fr / Biopolis 38700 La Tronche / +33 4 76 63 75 90
SILLIBIOPRINT is being created, devoted to the industrial valorization of the Brain-Print concept to develop molecular targeted therapies for neurodegenerative diseases. Awarded Biovision prize 2014. (Clinatec)